[Evaluation of certain leukocyte subpopulations in the peripheral blood and cerebrospinal fluid in multiple sclerosis]. 1979

J Czernicki, and Z Maciejek, and A Jurkowski

Using a mixed rosette technique the counts of lymphocytes forming rosettes E and EA and non-rosette-forming lymphocytes were determined in the peripheral blood and cerebrospinal fluid in 15 multiple sclerosis patients and 17 controls. A rise was observed in the percent and absolute value of non-rosette-forming lymphocytes in the peripheral blood and cerebrospinal fluid in these patients. Various immunological aspects of this fact in the pathogenesis of multiple sclerosis are discussed.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012397 Rosette Formation The in vitro formation of clusters consisting of a cell (usually a lymphocyte) surrounded by antigenic cells or antigen-bearing particles (usually erythrocytes, which may or may not be coated with antibody or antibody and complement). The rosette-forming cell may be an antibody-forming cell, a memory cell, a T-cell, a cell bearing surface cytophilic antibodies, or a monocyte possessing Fc receptors. Rosette formation can be used to identify specific populations of these cells. Immunocytoadherence,Formation, Rosette,Formations, Rosette,Immunocytoadherences,Rosette Formations
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

J Czernicki, and Z Maciejek, and A Jurkowski
September 1980, Acta neurologica Scandinavica,
J Czernicki, and Z Maciejek, and A Jurkowski
July 1980, Acta neurologica Scandinavica,
J Czernicki, and Z Maciejek, and A Jurkowski
January 1975, Scandinavian journal of immunology,
J Czernicki, and Z Maciejek, and A Jurkowski
January 1982, Bollettino dell'Istituto sieroterapico milanese,
J Czernicki, and Z Maciejek, and A Jurkowski
February 1986, Italian journal of neurological sciences,
J Czernicki, and Z Maciejek, and A Jurkowski
March 1984, Acta neurologica Scandinavica,
J Czernicki, and Z Maciejek, and A Jurkowski
January 1984, Annals of the New York Academy of Sciences,
J Czernicki, and Z Maciejek, and A Jurkowski
December 1983, Clinical immunology and immunopathology,
Copied contents to your clipboard!